<DOC>
	<DOCNO>NCT00474409</DOCNO>
	<brief_summary>The purpose study determine efficacy safety Betahistine Mesilate treatment patient vertigo caused Cerebral Infarction posterior circulation .</brief_summary>
	<brief_title>A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Vertigo</mesh_term>
	<mesh_term>Dizziness</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Betahistine</mesh_term>
	<criteria>1 . Patients clinical diagnosis posterior circulation infarction vertigo occur within 1 month infarction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Vertigo</keyword>
	<keyword>Posterior circulation infarction</keyword>
</DOC>